KING OF PRUSSIA, Pa.,
July 7, 2016 /PRNewswire/ -- Trice
Medical today announced the appointment of Mark Foster as chief commercialization officer
and vice president, worldwide sales. In this newly created role,
Foster will lead the company's product commercialization and sales
worldwide, working closely with the product development,
operations, sales and marketing teams to solidify Trice Medical's
position as a leader in the orthopedic industry while identifying
and executing upon the company's growth and strategic
opportunities. Foster joins Trice Medical's executive team and
reports directly to the company's CEO, Jeff
O'Donnell, Sr.
"Mark is a consummate leader and a solid addition to our team,"
said O'Donnell. "He has an impressive track record, a deep
understanding of the orthopedic and global markets, and a vision
for how Trice and its products will transform them. I am proud and
excited that Mark has joined us to lead the next phase of both our
company's and this industry's evolution."
Foster comes to Trice Medical after eight years with Smith &
Nephew, a global medical technology company; his last position with
Smith & Nephew was Vice President, U.S. Sports Medicine in the
Advanced Surgical Device Division. Earlier in his career, Foster
spent eight years with Boston Scientific as a regional manager, and
a director of operations and training. He started his healthcare
career with Smith Kline Beecham. He holds a B.A. from the
University of Richmond.
"Trice Medical is at the forefront of a revolution
in camera-enabled needle technology and has a unique
opportunity to bring value to patients, physicians and payers,"
said Foster. "Trice Medical's keen vision and the team's
impressive execution are reshaping this industry. The
opportunity to participate directly became an irresistible draw,
and I couldn't be more excited to help Trice Medical in this next
phase of growth."
About Trice Medical
Trice Medical was founded to fundamentally improve orthopedic
diagnostics for the patient, physician, and payor by providing
instant, eyes-on, answers. Trice Medical has pioneered fully
integrated camera-enabled technology, the mi-eye+, that provides a
clinical solution optimized for the physician's
office. Trice Medical's mission is to provide more immediate
and definitive patient care, eliminating the false reads associated
with current indirect modalities and significantly reduce the
overall cost to the healthcare system. Trice Medical is a
venture capital backed company; Safeguard Scientifics (NYSE: SFE),
BioStar Ventures and HealthQuest Capital are its major investors;
smaller firms and angel investors have completed the rounds.
For more information, visit www.tricemedical.com; follow
us
on Twitter, LinkedIn and Facebook
or call 610-989-8080.
Logo - http://photos.prnewswire.com/prnh/20160404/350851LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/trice-medical-appoints-mark-foster-chief-commercialization-officer-300295159.html
SOURCE Trice Medical